positionForPages[107]={page:107,positions:[{w:"Research Publications",p:[0.674285,0.063855,0.896201,0.063855,0.896201,0.040840,0.674285,0.040840,0.016980,0.010442,0.009149,0.010442,0.011759,0.010014,0.010442,0.013076,0.005456,0.014370,0.013076,0.013076,0.006538,0.006538,0.010442,0.011759,0.007832,0.006538,0.011759,0.013076,0.009149]},{w:"New 2-Alkoxycyanopyridine Derivatives As Inhibitors Of ",p:[0.104762,0.111208,0.809192,0.111208,0.809192,0.083261,0.104762,0.083261,0.020619,0.012680,0.020619,0.007140,0.014279,0.009510,0.020619,0.007939,0.015878,0.014279,0.014279,0.014279,0.012680,0.014279,0.014279,0.015878,0.014279,0.015878,0.014279,0.012680,0.007939,0.015878,0.007939,0.015878,0.012680,0.007140,0.020619,0.012680,0.012680,0.007939,0.014279,0.014279,0.009510,0.007939,0.014279,0.012680,0.011109,0.005555,0.020619,0.011109,0.007140,0.011109,0.015878,0.015878,0.007939,0.015878,0.007939,0.009510,0.014279,0.012680,0.011109,0.007140,0.022218,0.009510,0.007140]},{w:"Egfr, Her2, And Dhfr: Synthesis, Anticancer Evaluation, And ",p:[0.104762,0.137337,0.855294,0.137337,0.855294,0.109391,0.104762,0.109391,0.019048,0.014279,0.009510,0.010055,0.007140,0.007140,0.022218,0.012680,0.012680,0.014279,0.007140,0.005549,0.020619,0.015878,0.015878,0.007140,0.020619,0.015878,0.009510,0.012680,0.009510,0.007140,0.015878,0.014279,0.015878,0.009510,0.015878,0.012680,0.011109,0.007939,0.011109,0.007140,0.005595,0.020619,0.015878,0.009510,0.007939,0.012680,0.014279,0.015878,0.012680,0.012680,0.012157,0.007140,0.019048,0.014279,0.014279,0.007939,0.015878,0.014279,0.009510,0.007939,0.014279,0.015878,0.007140,0.005563,0.020619,0.015878,0.015878,0.007140]},{w:"Molecular Modeling Studies ",p:[0.104762,0.163466,0.455659,0.163466,0.455659,0.135520,0.104762,0.135520,0.026959,0.014279,0.007939,0.012680,0.012680,0.015878,0.007939,0.014279,0.012140,0.007140,0.026959,0.014279,0.015878,0.012680,0.007939,0.007939,0.015878,0.014279,0.007140,0.015878,0.009510,0.015878,0.015878,0.007939,0.012680,0.011109,0.007140]},{w:"Bioorganic And Medicinal Chemistry. 2023 Dec; 141: 106874.",p:[0.198548,0.188085,0.802407,0.188085,0.802407,0.165818,0.198548,0.165818,0.015687,0.006538,0.011759,0.011759,0.009149,0.011759,0.011759,0.013076,0.006538,0.010442,0.005002,0.015687,0.013076,0.011759,0.005880,0.020908,0.010442,0.011759,0.006538,0.010442,0.006538,0.013076,0.011759,0.006538,0.005880,0.015687,0.013076,0.010442,0.018297,0.006538,0.009149,0.006538,0.009149,0.009553,0.005880,0.005880,0.011759,0.011759,0.011759,0.011759,0.005880,0.016980,0.010442,0.010442,0.007832,0.005880,0.011759,0.011759,0.011759,0.007832,0.005880,0.011759,0.011759,0.011759,0.011759,0.011759,0.011759,0.005880]},{w:"------------------------------------------------------------------------------------",p:[0.171549,0.214209,0.829408,0.214209,0.829408,0.191810,0.171549,0.191810,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832]},{w:"Samia S Hawas , Selwan M El-Sayed, Perihan A Elzahhar, Mohamed A Moustafa",p:[0.132061,0.239984,0.868883,0.239984,0.868883,0.219308,0.132061,0.219308,0.012142,0.010919,0.016990,0.006071,0.010919,0.005460,0.012142,0.005460,0.016990,0.010919,0.014566,0.010919,0.008495,0.005460,0.005460,0.005460,0.012142,0.009696,0.006071,0.014566,0.010919,0.012142,0.005460,0.019415,0.005460,0.014566,0.006071,0.007272,0.012142,0.010919,0.009696,0.009696,0.010919,0.005460,0.005460,0.013343,0.009696,0.008495,0.006071,0.012142,0.010919,0.012142,0.004643,0.013363,0.005460,0.014566,0.006071,0.008495,0.010919,0.012142,0.012142,0.010919,0.007298,0.005460,0.005460,0.019415,0.010919,0.012142,0.010919,0.016990,0.009696,0.010919,0.004649,0.013361,0.005460,0.019415,0.010919,0.012142,0.008495,0.006071,0.010919,0.007272,0.010919]},{w:"Vol. 2 - Issue 1",p:[0.743337,0.965677,0.857137,0.965677,0.857137,0.947594,0.743337,0.947594,0.011649,0.009239,0.005137,0.004620,0.004620,0.009239,0.004620,0.006153,0.004620,0.007188,0.007188,0.007188,0.010274,0.008205,0.004620,0.009239]},{w:"Reference:",p:[0.104762,0.682192,0.210548,0.682192,0.210548,0.659926,0.104762,0.659926,0.015687,0.010442,0.007832,0.010442,0.009149,0.010442,0.013076,0.010442,0.010442,0.007832]},{w:"https://doi.org/10.1016/j.bioorg.2023.106874",p:[0.104762,0.701721,0.407939,0.701721,0.407939,0.685722,0.104762,0.685722,0.008399,0.004670,0.004670,0.008399,0.006535,0.004670,0.004670,0.004670,0.008399,0.008399,0.004670,0.004200,0.008399,0.005277,0.008399,0.004670,0.008399,0.008399,0.004200,0.008399,0.008399,0.008399,0.008399,0.004670,0.004670,0.004200,0.008399,0.004670,0.008399,0.008399,0.005280,0.008399,0.004200,0.008399,0.008399,0.008399,0.008399,0.004200,0.008399,0.008399,0.008399,0.008399,0.008399,0.008399]},{w:"Abstract",p:[0.104762,0.303728,0.213026,0.303728,0.213026,0.275781,0.104762,0.275781,0.020905,0.016164,0.011395,0.009795,0.012965,0.014565,0.012965,0.009510]},{w:"New series of substituted 2-alkoxycyanopyridine derivatives were synthesized and evaluated for ",p:[0.104762,0.325319,0.900366,0.325319,0.900366,0.306119,0.104762,0.306119,0.014756,0.009152,0.014756,0.004717,0.008043,0.009152,0.006914,0.005806,0.009152,0.008043,0.004717,0.010281,0.006914,0.004717,0.008043,0.010281,0.010281,0.008043,0.005806,0.005806,0.005806,0.010281,0.005806,0.009152,0.010281,0.004717,0.010281,0.006914,0.009152,0.005806,0.010281,0.010281,0.010281,0.010281,0.009152,0.010281,0.009152,0.010281,0.010281,0.010281,0.010281,0.006914,0.005806,0.010281,0.005806,0.010281,0.009152,0.004717,0.010281,0.009152,0.006914,0.005806,0.010281,0.009152,0.005806,0.005806,0.010281,0.009152,0.008043,0.004717,0.014756,0.009152,0.006914,0.009152,0.004717,0.008043,0.010281,0.010281,0.005806,0.010281,0.009152,0.008043,0.005806,0.009152,0.009152,0.010281,0.004717,0.009152,0.010281,0.010281,0.004717,0.009152,0.010281,0.009152,0.005806,0.010281,0.009152,0.005806,0.009152,0.010281,0.004717,0.006914,0.010281,0.006713,0.005040]},{w:"their in vitro and in vivo anticancer activities. Comparing the evaluated activities against cancer ",p:[0.104762,0.342423,0.900346,0.342423,0.900346,0.323224,0.104762,0.323224,0.005806,0.010281,0.009152,0.005806,0.006914,0.005100,0.005806,0.010281,0.005100,0.010281,0.005806,0.005806,0.006914,0.010281,0.005100,0.009152,0.010281,0.010281,0.005100,0.005806,0.010281,0.005100,0.010281,0.005806,0.010281,0.010281,0.005100,0.009152,0.010281,0.005806,0.005806,0.009152,0.009152,0.010281,0.009152,0.009152,0.006914,0.005100,0.009152,0.009152,0.005806,0.005806,0.010281,0.005806,0.005806,0.005806,0.009152,0.008043,0.005241,0.005100,0.013647,0.010281,0.015885,0.010281,0.009152,0.006914,0.005806,0.010281,0.010281,0.005100,0.005806,0.010281,0.009152,0.005100,0.009152,0.010281,0.009152,0.005806,0.010281,0.009152,0.005806,0.009152,0.010281,0.005100,0.009152,0.009152,0.005806,0.005806,0.010281,0.005806,0.005806,0.005806,0.009152,0.008043,0.005100,0.009152,0.010281,0.009152,0.005806,0.010281,0.008043,0.005806,0.005100,0.009152,0.009152,0.010281,0.009152,0.009152,0.006713,0.005040]},{w:"cell lines to the broad-spectrum anticancer doxorubicin, and the kinase inhibitor sorafenib, ",p:[0.104762,0.359528,0.900447,0.359528,0.900447,0.340328,0.104762,0.340328,0.009152,0.009152,0.005806,0.005806,0.009132,0.005806,0.005806,0.010281,0.009152,0.008043,0.009132,0.005806,0.010281,0.009132,0.005806,0.010281,0.009152,0.009132,0.010281,0.006914,0.010281,0.009152,0.010281,0.006914,0.008043,0.010281,0.009152,0.009152,0.005806,0.006914,0.010281,0.015885,0.009132,0.009152,0.010281,0.005806,0.005806,0.009152,0.009152,0.010281,0.009152,0.009152,0.006914,0.009132,0.010281,0.010281,0.010281,0.010281,0.006914,0.010281,0.010281,0.005806,0.009152,0.005806,0.010281,0.005241,0.009132,0.009152,0.010281,0.010281,0.009132,0.005806,0.010281,0.009152,0.009132,0.010281,0.005806,0.010281,0.009152,0.008043,0.009152,0.009132,0.005806,0.010281,0.010281,0.005806,0.010281,0.005806,0.005806,0.010281,0.006914,0.009132,0.008043,0.010281,0.006914,0.009152,0.006914,0.009152,0.010281,0.005806,0.010281,0.005040,0.005040]},{w:"compounds 3a, 4b, 4c, 7a, and 8d demonstrated superior anticancer efficacy with elevated safety ",p:[0.104762,0.376632,0.900283,0.376632,0.900283,0.357432,0.104762,0.357432,0.009152,0.010281,0.015885,0.010281,0.010281,0.010281,0.010281,0.010281,0.008043,0.004717,0.010281,0.009152,0.005241,0.004717,0.010281,0.010281,0.005241,0.004717,0.010281,0.009152,0.005241,0.004717,0.010281,0.009152,0.005241,0.004717,0.009152,0.010281,0.010281,0.004717,0.010281,0.010281,0.004717,0.010281,0.009152,0.015885,0.010281,0.010281,0.008043,0.005806,0.006914,0.009152,0.005806,0.009152,0.010281,0.004717,0.008043,0.010281,0.010281,0.009152,0.006914,0.005806,0.010281,0.006914,0.004717,0.009152,0.010281,0.005806,0.005806,0.009152,0.009152,0.010281,0.009152,0.009152,0.006914,0.004717,0.009152,0.006550,0.006914,0.005806,0.009152,0.009152,0.009152,0.010281,0.004717,0.014756,0.005806,0.005806,0.010281,0.004717,0.009152,0.005806,0.009152,0.010281,0.009152,0.005806,0.009152,0.010281,0.004717,0.008043,0.009152,0.006914,0.009152,0.005806,0.010079,0.005040]},{w:"profiles and selectivity indices, particularly against MCF7 breast cancer. For exploration of their ",p:[0.104762,0.393736,0.900386,0.393736,0.900386,0.374537,0.104762,0.374537,0.010281,0.006914,0.010281,0.006914,0.005806,0.005806,0.009152,0.008043,0.004717,0.009152,0.010281,0.010281,0.004717,0.008043,0.009152,0.005806,0.009152,0.009152,0.005806,0.005806,0.010281,0.005806,0.005806,0.010281,0.004717,0.005806,0.010281,0.010281,0.005806,0.009152,0.009152,0.008043,0.005241,0.004717,0.010281,0.009152,0.006914,0.005806,0.005806,0.009152,0.010281,0.005806,0.009152,0.006914,0.005806,0.010281,0.004717,0.009152,0.010281,0.009152,0.005806,0.010281,0.008043,0.005806,0.004717,0.018123,0.013647,0.011410,0.010281,0.004717,0.010281,0.006914,0.009152,0.009152,0.008043,0.005806,0.004717,0.009152,0.009152,0.010281,0.009152,0.009152,0.005804,0.005241,0.004717,0.011410,0.010281,0.006914,0.004717,0.009152,0.010281,0.010281,0.005806,0.010281,0.006914,0.009152,0.005806,0.005806,0.010281,0.010281,0.004717,0.010281,0.006914,0.004717,0.005806,0.010281,0.009152,0.005806,0.006715,0.005040]},{w:"mechanism of action, assays for inhibition of EGFR, HER2 kinase, and DHFR were performed. ",p:[0.104762,0.410841,0.900225,0.410841,0.900225,0.391641,0.104762,0.391641,0.015885,0.009152,0.009152,0.010281,0.009152,0.010281,0.005806,0.008043,0.015885,0.005201,0.010281,0.006914,0.005201,0.009152,0.009152,0.005806,0.005806,0.010281,0.010281,0.005241,0.005201,0.009152,0.008043,0.008043,0.009152,0.010281,0.008043,0.005201,0.006914,0.010281,0.006914,0.005201,0.005806,0.010281,0.010281,0.005806,0.010281,0.005806,0.005806,0.005806,0.010281,0.010281,0.005201,0.010281,0.006914,0.005201,0.012519,0.014756,0.011410,0.013647,0.005241,0.005201,0.014756,0.012519,0.013647,0.010281,0.005201,0.010281,0.005806,0.010281,0.009152,0.008043,0.009152,0.005241,0.005201,0.009152,0.010281,0.010281,0.005201,0.014756,0.014756,0.011410,0.013647,0.005201,0.014756,0.009152,0.006914,0.009152,0.005201,0.010281,0.009152,0.006914,0.006914,0.010281,0.006914,0.015885,0.009152,0.010281,0.005040,0.005040]},{w:"The promising synthesized compounds exhibited potent dual kinase EGFR/HER2 inhibitory ",p:[0.104762,0.427945,0.900305,0.427945,0.900305,0.408745,0.104762,0.408745,0.012519,0.010281,0.009152,0.008507,0.010281,0.006914,0.010281,0.015885,0.005806,0.008043,0.005806,0.010281,0.010281,0.008507,0.008043,0.010281,0.010281,0.005806,0.010281,0.009152,0.008043,0.005806,0.009152,0.009152,0.010281,0.008507,0.009152,0.010281,0.015885,0.010281,0.010281,0.010281,0.010281,0.010281,0.008043,0.008507,0.009152,0.010281,0.010281,0.005806,0.010281,0.005806,0.005806,0.009152,0.010281,0.008507,0.010281,0.010281,0.005806,0.009152,0.010281,0.005806,0.008507,0.010281,0.010281,0.009152,0.005806,0.008507,0.010281,0.005806,0.010281,0.009152,0.008043,0.009152,0.008507,0.012519,0.014756,0.011410,0.013647,0.005806,0.014756,0.012519,0.013647,0.010281,0.008507,0.005806,0.010281,0.010281,0.005806,0.010281,0.005806,0.005806,0.010281,0.006914,0.010079,0.005040]},{w:"activity with IC50 values of 0.248/0.156 μM for 4b and 0.138/0.092 μM for 4c. Additionally, ",p:[0.104762,0.445049,0.900328,0.445049,0.900328,0.425850,0.104762,0.425850,0.009152,0.009152,0.005806,0.005806,0.010281,0.005806,0.005806,0.010281,0.006806,0.014756,0.005806,0.005806,0.010281,0.006806,0.006914,0.013647,0.010281,0.010281,0.006808,0.010281,0.009152,0.005806,0.010281,0.009152,0.008043,0.006808,0.010281,0.006914,0.006806,0.010281,0.005241,0.010281,0.010281,0.010281,0.005806,0.010281,0.005241,0.010281,0.010281,0.010281,0.006808,0.011007,0.018123,0.006806,0.006914,0.010281,0.006914,0.006806,0.010281,0.010281,0.006808,0.009152,0.010281,0.010281,0.006808,0.010281,0.005241,0.010281,0.010281,0.010281,0.005806,0.010281,0.005241,0.010281,0.010281,0.010281,0.006806,0.011007,0.018123,0.006808,0.006914,0.010281,0.006914,0.006808,0.010281,0.009152,0.005241,0.005695,0.014756,0.010281,0.010281,0.005806,0.005806,0.005806,0.010281,0.010281,0.009152,0.005806,0.005806,0.008973,0.005040,0.005040]},{w:"with IC50 values of 0.138 and 0.193 M, respectively, 4b and 4c had the greatest DHFR inhibitory ",p:[0.104762,0.462154,0.900305,0.462154,0.900305,0.442954,0.104762,0.442954,0.014756,0.005806,0.005806,0.010281,0.004274,0.006914,0.013647,0.010281,0.010281,0.004274,0.010281,0.009152,0.005806,0.010281,0.009152,0.008043,0.004274,0.010281,0.006914,0.004274,0.010281,0.005241,0.010281,0.010281,0.010281,0.004274,0.009152,0.010281,0.010281,0.004274,0.010281,0.005241,0.010281,0.010281,0.010281,0.004274,0.018123,0.005241,0.004274,0.006914,0.009152,0.008043,0.010281,0.009152,0.009152,0.005806,0.005806,0.010281,0.009152,0.005806,0.008971,0.005241,0.004274,0.010281,0.010281,0.004274,0.009152,0.010281,0.010281,0.004274,0.010281,0.009152,0.004274,0.010281,0.009152,0.010281,0.004274,0.005806,0.010281,0.009152,0.004274,0.010281,0.006914,0.009152,0.009152,0.005806,0.009152,0.008043,0.005806,0.004274,0.014756,0.014756,0.011410,0.013647,0.004274,0.005806,0.010281,0.010281,0.005806,0.010281,0.005806,0.005806,0.010281,0.006914,0.010079,0.005040]},{w:"activity that was comparable to methotrexate. In the MCF7 breast cancer cell line, they caused ",p:[0.104762,0.479258,0.900386,0.479258,0.900386,0.460059,0.104762,0.460059,0.009152,0.009152,0.005806,0.005806,0.010281,0.005806,0.005806,0.010281,0.005987,0.005806,0.010281,0.009152,0.005806,0.005987,0.014756,0.009152,0.008043,0.005987,0.009152,0.010281,0.015885,0.010281,0.009152,0.006914,0.009152,0.010281,0.005806,0.009152,0.005987,0.005806,0.010281,0.005987,0.015885,0.009152,0.005806,0.010281,0.010281,0.005806,0.006914,0.009152,0.010281,0.009152,0.005806,0.009152,0.005241,0.005987,0.006914,0.010281,0.005987,0.005806,0.010281,0.009152,0.005987,0.018123,0.013647,0.011410,0.010281,0.005987,0.010281,0.006914,0.009152,0.009152,0.008043,0.005806,0.005987,0.009152,0.009152,0.010281,0.009152,0.009152,0.006914,0.005987,0.009152,0.009152,0.005806,0.005806,0.005987,0.005806,0.005806,0.010281,0.009152,0.005241,0.005987,0.005806,0.010281,0.009152,0.010281,0.005987,0.009152,0.009152,0.010281,0.008043,0.009152,0.010079,0.005040]},{w:"arrest at the S phase of the cell cycle and exhibited apoptosis induction activity. With restored ",p:[0.104762,0.496363,0.900396,0.496363,0.900396,0.477163,0.104762,0.477163,0.009152,0.006914,0.006914,0.009152,0.008043,0.005806,0.006360,0.009152,0.005806,0.006358,0.005806,0.010281,0.009152,0.006360,0.011410,0.006360,0.010281,0.010281,0.009152,0.008043,0.009152,0.006358,0.010281,0.006914,0.006360,0.005806,0.010281,0.009152,0.006358,0.009152,0.009152,0.005806,0.005806,0.006360,0.009152,0.010281,0.009152,0.005806,0.009152,0.006358,0.009152,0.010281,0.010281,0.006358,0.009152,0.010281,0.010281,0.005806,0.010281,0.005806,0.005806,0.009152,0.010281,0.006358,0.009152,0.010281,0.010281,0.010281,0.005806,0.010281,0.008043,0.005806,0.008043,0.006360,0.005806,0.010281,0.010281,0.010281,0.009152,0.005806,0.005806,0.010281,0.010281,0.006358,0.009152,0.009152,0.005806,0.005806,0.010281,0.005806,0.005806,0.008971,0.005241,0.005993,0.018423,0.005806,0.005806,0.010281,0.006360,0.006914,0.009152,0.008043,0.005806,0.010281,0.006914,0.009152,0.010079,0.005040]},{w:"caspase-3 immunoexpression, the anti-breast cancer assay performed in vivo of 4b and 4c ",p:[0.104762,0.513467,0.900342,0.513467,0.900342,0.494267,0.104762,0.494267,0.009152,0.009152,0.008043,0.010281,0.009152,0.008043,0.009152,0.006914,0.010281,0.009354,0.005806,0.015885,0.015885,0.010281,0.010281,0.010281,0.009152,0.010281,0.010281,0.006914,0.009152,0.008043,0.008043,0.005806,0.010281,0.010281,0.005241,0.009354,0.005806,0.010281,0.009152,0.009354,0.009152,0.010281,0.005806,0.005806,0.006914,0.010281,0.006914,0.009152,0.009152,0.008043,0.005806,0.009354,0.009152,0.009152,0.010281,0.009152,0.009152,0.006914,0.009354,0.009152,0.008043,0.008043,0.009152,0.010281,0.009354,0.010281,0.009152,0.006914,0.006914,0.010281,0.006914,0.015885,0.009152,0.010281,0.009354,0.005806,0.010281,0.009354,0.010281,0.005806,0.010281,0.010281,0.009354,0.010281,0.006914,0.009354,0.010281,0.010281,0.009354,0.009152,0.010281,0.010281,0.009354,0.010281,0.008946,0.005040]},{w:"demonstrated a substantial decrease in tumor volume. Results from molecular modeling were in ",p:[0.104762,0.530571,0.900386,0.530571,0.900386,0.511372,0.104762,0.511372,0.010281,0.009152,0.015885,0.010281,0.010281,0.008043,0.005806,0.006914,0.009152,0.005806,0.009152,0.010281,0.005161,0.009152,0.005161,0.008043,0.010281,0.010281,0.008043,0.005806,0.009152,0.010281,0.005806,0.005806,0.009152,0.005806,0.005161,0.010281,0.009152,0.009152,0.006914,0.009152,0.009152,0.008043,0.009152,0.005161,0.005806,0.010281,0.005161,0.005806,0.010281,0.015885,0.010281,0.006914,0.005161,0.010281,0.010281,0.005806,0.010281,0.015885,0.009152,0.005241,0.005161,0.013647,0.009152,0.008043,0.010281,0.005806,0.005806,0.008043,0.005161,0.006914,0.006914,0.010281,0.015885,0.005161,0.015885,0.010281,0.005806,0.009152,0.009152,0.010281,0.005806,0.009152,0.006914,0.005161,0.015885,0.010281,0.010281,0.009152,0.005806,0.005806,0.010281,0.010281,0.005161,0.014756,0.009152,0.006914,0.009152,0.005161,0.005806,0.010079,0.005040]},{w:"agreement with biological assays proving the importance of the 3-caynopyridine, two substituted ",p:[0.104762,0.547676,0.900386,0.547676,0.900386,0.528476,0.104762,0.528476,0.009152,0.010281,0.006914,0.009152,0.009152,0.015885,0.009152,0.010281,0.005806,0.004334,0.014756,0.005806,0.005806,0.010281,0.004334,0.010281,0.005806,0.010281,0.005806,0.010281,0.010281,0.005806,0.009152,0.009152,0.005806,0.004334,0.009152,0.008043,0.008043,0.009152,0.010281,0.008043,0.004334,0.010281,0.006914,0.010281,0.010281,0.005806,0.010281,0.010281,0.004334,0.005806,0.010281,0.009152,0.004334,0.005806,0.015885,0.010281,0.010281,0.006914,0.005806,0.009152,0.010281,0.009152,0.009152,0.004334,0.010281,0.006914,0.004334,0.005806,0.010281,0.009152,0.004334,0.010281,0.006914,0.009152,0.009152,0.010281,0.010281,0.010281,0.010281,0.010281,0.006914,0.005806,0.010281,0.005806,0.010281,0.009152,0.005241,0.004334,0.005806,0.014756,0.010281,0.004334,0.008043,0.010281,0.010281,0.008043,0.005806,0.005806,0.005806,0.010281,0.005806,0.009152,0.010079,0.005040]},{w:"phenyl rings attached to central pyridine ring, and propoxy side chain moieties for binding with ",p:[0.104762,0.564780,0.900436,0.564780,0.900436,0.545580,0.104762,0.545580,0.010281,0.010281,0.009152,0.010281,0.010281,0.005806,0.005362,0.006914,0.005806,0.010281,0.010281,0.008043,0.005352,0.009152,0.005806,0.005806,0.009152,0.009152,0.010281,0.009152,0.010281,0.005362,0.005806,0.010281,0.005362,0.009152,0.009152,0.010281,0.005806,0.006914,0.009152,0.005806,0.005362,0.010281,0.010281,0.006914,0.005806,0.010281,0.005806,0.010281,0.009152,0.005362,0.006914,0.005806,0.010281,0.010281,0.005241,0.005352,0.009152,0.010281,0.010281,0.005352,0.010281,0.006914,0.010281,0.010281,0.010281,0.010281,0.010281,0.005352,0.008043,0.005806,0.010281,0.009152,0.005352,0.009152,0.010281,0.009152,0.005806,0.010281,0.005352,0.015885,0.010281,0.005806,0.009152,0.005806,0.005806,0.009152,0.008043,0.005362,0.006914,0.010281,0.006914,0.005362,0.010281,0.005806,0.010281,0.010281,0.005806,0.010281,0.010281,0.005352,0.014756,0.005806,0.005806,0.010079,0.005040]},{w:"the receptors. As 4c works by inhibiting both EGFR/HER2 kinase, DHFR enzymes, in addition ",p:[0.104762,0.581884,0.900249,0.581884,0.900249,0.562685,0.104762,0.562685,0.005806,0.010281,0.009152,0.005584,0.006914,0.009152,0.009152,0.009152,0.010281,0.005806,0.010281,0.006914,0.008043,0.005241,0.004479,0.014756,0.008043,0.005584,0.010281,0.009152,0.005584,0.014756,0.010281,0.006914,0.010281,0.008043,0.005584,0.010281,0.010281,0.005584,0.005806,0.010281,0.010281,0.005806,0.010281,0.005806,0.005806,0.005806,0.010281,0.010281,0.005584,0.010281,0.010281,0.005806,0.010281,0.005584,0.012519,0.014756,0.011410,0.013647,0.005806,0.014756,0.012519,0.013647,0.010281,0.005584,0.010281,0.005806,0.010281,0.009152,0.008043,0.009152,0.005241,0.005584,0.014756,0.014756,0.011410,0.013647,0.005584,0.009152,0.010281,0.009152,0.010281,0.015885,0.009152,0.008043,0.005241,0.005584,0.005806,0.010281,0.005584,0.009152,0.010281,0.010281,0.005806,0.005806,0.005806,0.010281,0.010079,0.005040]},{w:"to cellular apoptosis, it could be viewed as a model of compounds possessing a multi-targeting ",p:[0.104762,0.598989,0.900386,0.598989,0.900386,0.579789,0.104762,0.579789,0.005806,0.010281,0.005886,0.009152,0.009152,0.005806,0.005806,0.010281,0.005806,0.009152,0.006914,0.005886,0.009152,0.010281,0.010281,0.010281,0.005806,0.010281,0.008043,0.005806,0.008043,0.005241,0.005886,0.005806,0.005806,0.005886,0.009152,0.010281,0.010281,0.005806,0.010281,0.005886,0.010281,0.009152,0.005886,0.010281,0.005806,0.009152,0.014756,0.009152,0.010281,0.005886,0.009152,0.008043,0.005886,0.009152,0.005886,0.015885,0.010281,0.010281,0.009152,0.005806,0.005886,0.010281,0.006914,0.005886,0.009152,0.010281,0.015885,0.010281,0.010281,0.010281,0.010281,0.010281,0.008043,0.005886,0.010281,0.010281,0.008043,0.008043,0.009152,0.008043,0.008043,0.005806,0.010281,0.010281,0.005886,0.009152,0.005886,0.015885,0.010281,0.005806,0.005806,0.005806,0.006914,0.005806,0.009152,0.006550,0.010281,0.009152,0.005806,0.005806,0.010281,0.010081,0.005040]},{w:"anticancer activity. Collectively, compounds 4b and 4c might represent prototypes for further ",p:[0.104762,0.616093,0.900428,0.616093,0.900428,0.596894,0.104762,0.596894,0.009152,0.010281,0.005806,0.005806,0.009152,0.009152,0.010281,0.009152,0.009152,0.006914,0.007207,0.009152,0.009152,0.005806,0.005806,0.010281,0.005806,0.005806,0.008971,0.005241,0.007217,0.013647,0.010281,0.005806,0.005806,0.009152,0.009152,0.005806,0.005806,0.010281,0.009152,0.005806,0.008973,0.005241,0.007207,0.009152,0.010281,0.015885,0.010281,0.010281,0.010281,0.010281,0.010281,0.008043,0.007207,0.010281,0.010281,0.007217,0.009152,0.010281,0.010281,0.007217,0.010281,0.009152,0.007217,0.015885,0.005806,0.010281,0.010281,0.005806,0.007207,0.006914,0.009152,0.010281,0.006914,0.009152,0.008043,0.009152,0.010281,0.005806,0.007217,0.010281,0.006914,0.010281,0.005806,0.010281,0.005806,0.010281,0.010281,0.009152,0.008043,0.007207,0.006914,0.010281,0.006914,0.007207,0.006914,0.010281,0.006914,0.005806,0.010281,0.009152,0.006713,0.005040]},{w:"development as anticancer molecules.",p:[0.104762,0.633198,0.421234,0.633198,0.421234,0.613998,0.104762,0.613998,0.010281,0.009152,0.010281,0.009152,0.005806,0.010281,0.010281,0.015885,0.009152,0.010281,0.005806,0.006491,0.009152,0.008043,0.006491,0.009152,0.010281,0.005806,0.005806,0.009152,0.009152,0.010281,0.009152,0.009152,0.006914,0.006491,0.015885,0.010281,0.005806,0.009152,0.009152,0.010281,0.005806,0.009152,0.008043,0.005040]},{w:"107",p:[0.864761,0.971012,0.911903,0.971012,0.911903,0.940075,0.864761,0.940075,0.015300,0.015300,0.016540]}]};